BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Angiogenesis, Obesity, Neuron, Nosology, Fluoxetine, rs6983267, LEP)
Bookmark Forward

QuickView for suberoylanilide hydroxamic acid (compound)


Genetic Markers

Most Correlated Genes

  1. DHRS2
  2. H1F0
  3. CLIC3
  4. CFD
  5. DACT3
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. heterocyclic compound binding
  2. organic cyclic compound binding
  3. organic cyclic compound metabolic process
  4. heterocycle metabolic process
  5. cellular aromatic compound metabolic process
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Pancreatic cell lines treated with chromatin-targeting small molecules
  2. Pre-cursor B cell acute lymphoblastic leukemia cells and patient samples treated with vorinostat
  3. CD4-positive T cells from healthy donors treated with suberoylanilide hydroxamic acid
  4. Foreskin fibroblast BJ cells tumorigenic or normal treated with vorinostat
  5. Prostate cancer cells treated with Genistein and Vorinostat
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat.
  2. A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for …
  3. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparti…
  4. The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy …
  5. The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors
  2. Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
  3. Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Loca…
  4. Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
  5. Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Sma…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.